Using fluorescence in situ hybridization analysis, breakpoints involving the long arm of chromosome 1 (1q) were localized in 36 patients with various hematopoietic disorders and rearrangements of the proximal part of 1q, as ascertained with banding techniques. The breakpoint was localized within the satellite II (sat II) domain in 14 patients with various abnormalities, between the sat II domain and the BCL9 locus in eight, between the BCL9 and ARNT loci in two, between sat II and ARNT in two others, and distal to ARNT in seven. A dicentric chromosome 1 was present in two patients. A high incidence of heterochromatin heteromorphism of chromosome 1 was present in this series. Two recurrent translocations were identified, t(1;2)(q12;q37) in three patients suffering from three different acute leukemia subtypes, and t(1;16)(q12;q24) in two patients with different diseases. Two patients had jumping translocations. Most of the rearrangements of 1q were secondary abnormalities, included in complex karyotypes. The roles of methylation, interactions with the proteins interfering with heterochromatin and possible gene silencing due to heterochromatin rearrangements are discussed.
Introduction
Rearrangements of the long arm of chromosome 1 (1q) have been recognized to occur in various hematopoietic malignant disorders as early as banding techniques were applied to their study. 1, 2 Translocations, complete and partial trisomies, and deletions involving 1q are indeed commonly present in various leukemia subtypes, myeloproliferative disorders, myelodysplastic syndromes, and lymphoid proliferations. 3 They may occur both as 'primary' or 'secondary' chromosomal abnormalities in different patients. The breakpoints are variable and several affect identified gene loci. The most frequent recurrent translocation identified to date is t(1;19)(q23;p13) in acute lymphoblastic leukemia resulting in E2A-PBX1 fusion gene. 3 Translocation t(1;11)(q21;q23) fuses the AF1q and MLL genes, 3 t(1;12)(q21;p13) fuses ARNT and ETV6/TEL 4 (and unpublished data), and t(1;14)(q21;q32) involves BCL9 and IGH. 5 Centric and pericentric chromosome rearrangements have been recently claimed to occur more frequently than hitherto admitted. 6 To investigate more precisely for the possible recurrence of breakpoint localizations, we have extended the cytogenetic and FISH (fluorescence in situ hybridization) analysis of rearrangements of the long arm of chromosome 1 in 36 patients with various hematopoietic malignancies. It seems to us that the demonstration of the recurrence of some chromosomal breakpoints with banding and FISH techniques precedes any research on the mechanisms resulting in the rearrangements, as well as their molecular consequences.
Materials and methods

Patients
The 36 patients with hematopoietic disorders included in the present work were selected on the basis of the presence of 1q rearrangements as detected by banding techniques. They were initially studied in different French centers (Hô pital Saint Louis, Paris; U301 and 434 INSERM, Paris; Hopital Necker-Enfants Malades, Paris; CHU de Poitiers; CHU d'Angers; CHU de Toulouse; Institut Paoli-Calmettes, Marseille). The patients were examined for various hematopoietic malignancies mainly at diagnosis, and some in relapse, as summarized in Table 1. FISH studies were performed using probes covering repeated sequences specific to the chromosome 1 centromeric area and YAC probes covering loci located in the 1q proximal regions. These probes were D1Z5 (chromosome 1-specific alpha satellite; Appligene Oncor, Montreuil-sous-bois, France), CEP1 (chromosome 1-specific satellite II-III; Vysis, Voisin le Bretonneux, France), CB2 (chromosome 1-specific satellite II; M Jeanpierre, Service de Biochimie, Hô pital Cochin, Paris), YAC 882b3 covering the gene BCL9, 5 and BAC 904E5 covering the gene ARNT (CEPH, Paris, France). Preliminary experiments showed the following order of the loci on chromosome 1: centromere-BCL9-ARNT-AF1q-PBX1-telomere. The BCL9 and ARNT loci were chosen because both were located within band 1q21 and because the aim of this study was mainly to identify rearrangements closely located to the chromosome 1 heterochromatin. Telomeric probes were also used: cosmid probes corresponding to 2q and 16q (L Kearney, MRC, Molecular Haematology, Oxford, UK), and YAC 75 corresponding to 2q (D Le Paslier, CEPH, Paris, France).
Techniques were performed as previously described 6 or following the instructions of the manufacturers for the commercial probes. The metaphase chromosomes were counterstained by propidium iodide in monocolor and DAPI in bicolor FISH studies.
The presence of asymmetry of heterochromatin area (length, partial inversion) between the two homologuous chromosomes 1 defining heterochromatin heteromorphism was systematically noted in reference to its possible significance as a constitutional factor favoring chromosomal rearrangements. 
Results
Chromosome 1 rearrangements were variable in the different patients. They were identified as translocations, deletions, or partial duplications by analysis of banded karyotypes. In most of the patients, they were part of complex karyotypes with more than three different abnormalities.
Localization of the chromosomal breakpoints on chromosome 1
The localization of the chromosome 1 breakpoints was refined by FISH analysis in every case. They were distributed within several intervals between 1cen and 1q23 ( Table 2 ).
The breakpoint was located within the satellite II domain Table 2 ). The corresponding hematological disorders were heterogeneous. Five patients (Nos 3-5, 9, 14) had simple karyotypes with translocations involving 1q, one had a partial 1q duplication associated with the common Burkitt leukemia translocation t(8;14) (No. 9) and the others had complex chromosomal rearrangements. The same rearrangement, der(2)t(1;2)(q12;q37) resulting in trisomy 1q was present in three patients with different leukemias, AML-M0 in patient 1, AML-M4 in patient 2 ( Figure 1) , and ALL-L1 in patient 8. The breakpoint on the rearranged chromosome 2 was distal to the localization of YAC and/or cosmid probes specific its telomeric region, as shown by FISH experiments in the three patients. Similarly, two der(16)t(1;16)(q12;q24) translocations were detected. FISH using the 16q telomeric cosmid probe showed a signal on the derivatives chromosomes 16 in the two patients. The breakpoints should consequently be located telomeric to these probes. In addition, a jumping translocation involving 1q12, with t(1;2), t(1;16), and t(1;19) was detected in patient 2, and another possible jumping translocation with t(1;1), t(1;11), t(1;12), t(1;21) was found in patient 7. Chromosome 1 heterochromatin asymmetry (heteromorphism) was present in eight out of 14 patients of this subgroup. The breakpoints were localized between the satellite II-III pericentromeric domain of chromosome 1 and the BCL9 locus (band 1q21) in eight patients (Nos 15 to 22) with various disorders. It is noteworthy that seven had lymphoid malignancies, ALL or non-Hodgkin malignant lymphoma (two with Burkitt-type proliferation). Six had complex karyotypes, while the patient with myeloid disorder had t(1;6) as the sole abnormality. Chromosome 1 heterochromatin heteromorphism was present in seven out of eight patients of this subgroup.
The breakpoints were localized between the BCL9 and ARNT loci on band 1q21 in three patients (Nos 23-25), one with AML-M1, another with myeloproliferative disorder in blastic transformation, and the third with chronic myelocytic leukemia in chronic phase. Two had simple translocations, t(1;16) and t(Y;1) respectively, and the third t(1;17) in addition to the t(9;22) tranlocation.
The breakpoints were located between the centromeric area and the ARNT locus in two other patients (Nos 26 and 27), one with ALL and the other with Burkitt lymphoma, both with complex karyotypes. A more precise localization of the breakpoint could not be done because of the shortage of material.
The chromosome 1q breakpoint was found to be telomeric to the ARNT locus in seven patients (Nos 28 to 34) with various disorders. The rearranged chromosomal bands were 1q21, 1q22, and even 1q23 in one patient, as defined by banding analysis, and it is well known that the distinction between 1q21 and 1q22 can be difficult in metaphases from patients with malignancies. Chromosome 1 heterochromatin heteromorphism was present in four out of the seven patients of this subgroup. Two patients (Nos 35 and 36) had dicentric chromosomes, ascertained using chromosome-specific probes. One with NHL in relapse had dic (1;7) , and the other with ALL-L2 of T lineage dic(1;9). Only the first patient with dic(1;7) had chromosome 1 heterochromatin heteromorphism.
Discussion
A series of 36 patients with various hematologic disorders and rearrangements of the proximal part of the long arm of chromosome 1 was collected from six cytogenetic laboratories in order to refine the localization of the breakpoints within 1q by FISH analysis. A previous study had indeed focused on the not uncommon occurrence of centromeric and pericentric rearrangements in hematopoietic malignancies, which could be difficult to ascertain without use of FISH techniques. 6 The breakpoints were localized within the satellite II domain, or between the alpha satellite and satellite II-III domains of chromosome 1 in 14 out of 36 patients, and between the satellite II-III domains and the BCL9 locus in eight patients.
Heteromorphism of chromosome 1 heterochromatin was present in 8/14 and 7/8 patients, respectively. Although no series of controls could be established because of the diversity of the recruitment of the patients (six centers), the proportion of patients with, vs those without heteromorphism seems to be high. Because of the variability of the frequency of heteromorphism in different populations, 7 the comparison of patients and controls remains to be carried out on more important series of individuals.
Three patients with der(2)t(1;2)(q12;q37) and three different subtypes of leukemia were detected. The t(1;2)(q12;q37) translocation appears to be a novel nonrandom chromosome abnormality of hematopoietic disorders. Although FISH experiments did not show hybridization of the 2q telomeric probes to the heterochromatin of chromosome 1, it is not possible to exclude the presence of homologous DNA repeated sequences on both chromosomes favoring the illegitimate recombination resulting in t(1;2) translocation. Three patients had t(1;16) translocation, two with breakpoints in 1q12 involving heterochromatin, and one 1q21 and 16q24. In the two translocations t(1;16)(q12;q24), which could be studied with 16q telomeric probes, hybridization signals were present on the derivative 16 chromosomes, and the same question about the existence of DNA sequence homology of 16q and heterochromatin of chromosome 1 should be addressed.
It is worth noting that telomeric regions are frequent partners of 1q in the rearrangements of the present series of patients (Table 1) . Homology between DNA sequences located in the vicinity of the chromosomal breakpoints could account for this observation.
Jumping translocations may involve various chromosomes. 8 Some cases of jumping translocations with involvement of bands 1q11-q21 have been previously reported in various hematopoietic malignancies. [9] [10] [11] [12] [13] [14] [15] In the two jumping translocations reported in the present study, the breakpoints were in heterochromatin, and the band 1q12 was the donor to several recipients. The mechanism of instability responsible for these jumping translocations is still unknown. Abnormal methylation and viral interaction have been hypothesized without experimental proof. Recently a novel membrane protein gene, named JTB, at 1q21 has been found rearranged in a jumping translocation of an acute myelomonocytic leukemia complicating a myelodysplastic syndrome with shortened telomeres. 15, 16 It is however too early to know if this rearrangement is casual or represents a more general abnormality.
Heteromorphism of heterochromatin was extensively studied since the late seventies when Atkin 17 suggested that it could be a constitutional marker for a high risk of malignant disease. [18] [19] [20] Despite some discrepancies, different studies showed differences of the distribution of heteromorphism frequencies between patients with malignancies and controls, with some variability among different malignancies. The results of these studies were based upon statistical analyses of series of patients. Because of the availability of molecular probes, the possible role of heteromorphism of heterochromatin as a factor predisposing to malignancy can now be reanalyzed at the molecular level. The analysis can consequently be performed at the indidual level and not only at the population level as in the past.
Moreover, data on molecular structure and composition of heterochromatin suggest a hypothesis on the formation of chromosomal rearrangements, as well as their functional consequences. As far as the production of rearrangements involving heterochromatin is concerned, several non-exclusive mechanisms can be hypothesized.
Abnormal pairing of heterochromatin between some distantly related sequences, although still controversial, can be particularly invoked in patients with chromosome 1 heterochromatin heteromorphism, which seems to be mainly related to different amounts of chromosome 1 DNA satellite II.
The methylation status of the centromeric DNA of chromosome 1 could be altered in malignancies. It is known that hypo-or demethylation of heterochromatin of chromosome 1, associated with DNA decondensation, makes it more prone to breakage and subsequent rearrangements.
The presence of retrotransposons within chromosome 1 heterochromatin has to be established but could also be involved in the generation of these abnormalities.
Finally, most of the rearrangements of chromosome 1 reported in the present study and in others are part of complex karyotypic abnormalities. This pattern of abnormalities strongly suggests their secondary nature, as it could reflect some instability of the genome of malignant cells.
The consequences of chromosomal rearrangements of centromeric and pericentromeric regions on the ADN or gene functions are speculative at the present time. Gene dosage imbalances can obviously result from these chromosomal rearrangements. One of the most tantalizing hypotheses about the functional consequences of the rearrangements involving heterochromatin is the silencing of genes closely located to heterochromatin that have been moved as a result of the chromosome abnormality. Variegation described in Drosophila has been related to such alterations, but very little data on the existence of similar mechanisms are available in man. Progress in gene mapping and sequencing will make it possible to identify such alterations. Another hypothesis regards the proteins associated with heterochromatin. For instance, the heterochromatin protein 1 (hp1) which prevents telomere fusion in Drosophila 21 could also interfere with chromosomal abnormalities of malignant cells in other species. Other proteins, such as those of the polycomb group complex and the co-repressor KAP-1 22, 23 are associated with heterochromatin and their functions can be altered by heterochromatin rearrangements. In support of this hypothesis, Ikaros complexes, associated with transcriptionally silent genes, are located at centromeric heterochromatin in mouse 24 could be functionally affected by changes in localization of heterochromatin and favor abnormal expression of some genes.
Although the role of speculation in these hypotheses remains important, it seems to us that rearrangements of heterochromatin in hematopoietic malignancies are now ascertained. If their real frequency remains to be determined, their identification opens the way to various investigations on the mechanisms of constitution of these abnormalities and their functional consequences.
